Next Edge Capital Corp. ("Next Edge" or the "Manager") announced that a preliminary prospectus for CMP Next Edge 2025 Critical and Precious Metals Short Duration Flow-Through Limited Partnership (the ...

WuXi Biologics is giving CDMO Terumo the keys to its site in Leverkusen, Germany, with a 150 million euros ($167 million) sale. With the deal, WuXi Biologics can “exclusivity focus” on ...

ADMA Biologics (NASDAQ:ADMA) will release its quarterly earnings report on Wednesday, 2025-05-07. Here's a brief overview for investors ahead of the announcement. Analysts anticipate ADMA ...

As per the latest analysis, the biosimilar and biologics market value is estimated to reach USD 520.9 billion in 2024. Global sales of biosimilars and biologics will likely increase at 7.6% CAGR ...

Stock Repurchase Program: Authorized up to $500 million. ADMA Biologics Inc (NASDAQ:ADMA) reported a 40% year-over-year increase in total revenues for Q1 2025, reaching $114.8 million. The company ...

Adma Biologics (ADMA) came out with quarterly earnings of $0.14 per share, missing the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.08 per share a year ago.

Y-Biologics, a company specializing in antibody drugs, announced on the 13th that it has signed a new antibody technology transfer agreement with LigaChem Biosciences to develop next-generation ...

EDISON, N.J. & SALT LAKE CITY--(BUSINESS WIRE)--MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research ...

SEATTLE & MILAN--(BUSINESS WIRE)--AGC Biologics, your friendly CDMO expert, today announced a partnership with Quell Therapeutics (“Quell”), a clinical-stage biotechnology company pioneering ...

The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics Evaluation and Research, the division that oversees vaccines and ...